Versigent PLC
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
VGNT$42.30+1.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (in millions, except per share amounts) | ||||
| Net sales | $2,450 | $2,286 | $7,106 | $6,516 |
| Operating expenses: | ||||
| Cost of sales | 2,120 | 1,990 | 6,211 | 5,708 |
| Selling, general and administrative | 112 | 104 | 309 | 313 |
| Amortization | — | — | 1 | 1 |
| Restructuring (Note 9) | 22 | 21 | 68 | 62 |
| Separation costs | 11 | 7 | 59 | 14 |
| Total operating expenses | 2,265 | 2,122 | 6,648 | 6,098 |
| Operating income | 185 | 164 | 458 | 418 |
| Interest expense | (36) | — | (77) | (3) |
| Other expense, net (Note 18) | (2) | — | (9) | (1) |
| Income before income taxes and equity income | 147 | 164 | 372 | 414 |
| Income tax expense (Note 13) | (35) | (54) | (72) | (104) |
| Income before equity income | 112 | 110 | 300 | 310 |
| Equity income, net of tax | — | 3 | 9 | 11 |
| Net income | 112 | 113 | 309 | 321 |
| Net income attributable to noncontrolling interest | 10 | 4 | 11 | 10 |
| Net income attributable to Versigent | $102 | $109 | $298 | $311 |
| Earnings per share attributable to Versigent: | ||||
| Basic | $1.44 | $1.54 | $4.20 | $4.39 |
| Diluted | $1.41 | $1.54 | $4.16 | $4.39 |
| Weighted average shares outstanding: | ||||
| Basic | 70.85 | 70.89 | 70.88 | 70.89 |
| Diluted | 72.25 | 70.89 | 71.67 | 70.89 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (in millions) | ||||
| Net income | $112 | $113 | $309 | $321 |
| Other comprehensive (loss) income: | ||||
| Currency translation adjustments | 4 | (6) | (26) | 51 |
| Net change in unrecognized (loss) gain on derivative instruments, net of tax (Note 15) | (30) | — | 76 | — |
| Employee benefit plans adjustment, net of tax (Note 15) | 1 | 1 | — | 1 |
| Other comprehensive (loss) income | (25) | (5) | 50 | 52 |
| Comprehensive income | 87 | 108 | 359 | 373 |
| Comprehensive income attributable to noncontrolling interests | 10 | 4 | 22 | 11 |
| Comprehensive income attributable to Versigent | $77 | $104 | $337 | $362 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.